Annual Current Assets
$57.67 M
+$42.52 M+280.66%
December 31, 2023
Summary
- As of February 8, 2025, XLO annual total current assets is $57.67 million, with the most recent change of +$42.52 million (+280.66%) on December 31, 2023.
- During the last 3 years, XLO annual current assets has risen by +$40.74 million (+240.66%).
- XLO annual current assets is now at all-time high.
Performance
XLO Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Assets
$63.31 M
-$14.70 M-18.84%
September 30, 2024
Summary
- As of February 8, 2025, XLO quarterly total current assets is $63.31 million, with the most recent change of -$14.70 million (-18.84%) on September 30, 2024.
- Over the past year, XLO quarterly current assets has increased by +$15.18 million (+31.55%).
- XLO quarterly current assets is now -68.74% below its all-time high of $202.52 million, reached on December 31, 2021.
Performance
XLO Quarterly Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Assets Formula
Current Assets = Cash and Equivalents + Accounts Receivable + Inventory + Prepaid Expenses + Marketable Securities + Other Current Assets
XLO Current Assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +280.7% | +31.6% |
| 3 y3 years | +240.7% | +31.6% |
| 5 y5 years | +2489.4% | +31.6% |
XLO Current Assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +360.7% | -68.7% | +31.6% |
| 5 y | 5-year | at high | +957.1% | -68.7% | +207.5% |
| alltime | all time | at high | +2489.4% | -68.7% | +207.5% |
Xilio Therapeutics Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $63.31 M(-18.8%) |
| Jun 2024 | - | $78.01 M(+12.8%) |
| Mar 2024 | - | $69.19 M(+43.8%) |
| Dec 2023 | $8.45 M(+322.9%) | $48.13 M(-25.4%) |
| Sep 2023 | - | $64.48 M(-17.8%) |
| Jun 2023 | - | $78.42 M(-19.1%) |
| Mar 2023 | - | $96.98 M(-22.1%) |
| Dec 2022 | $2.00 M | $124.50 M(-12.5%) |
| Sep 2022 | - | $142.31 M(-12.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $163.01 M(-10.0%) |
| Mar 2022 | - | $181.09 M(-10.6%) |
| Dec 2021 | $776.60 K(-9.1%) | $202.52 M(+91.8%) |
| Sep 2021 | - | $105.57 M(-15.3%) |
| Jun 2021 | - | $124.59 M(+505.1%) |
| Dec 2020 | $854.30 K(-23.1%) | $20.59 M |
| Dec 2019 | $1.11 M(+95.5%) | - |
| Dec 2018 | $567.90 K(+87.7%) | - |
| Dec 2017 | $302.50 K(+606.8%) | - |
| Dec 2016 | $42.80 K | - |
FAQ
- What is Xilio Therapeutics annual total current assets?
- What is the all time high annual current assets for Xilio Therapeutics?
- What is Xilio Therapeutics annual current assets year-on-year change?
- What is Xilio Therapeutics quarterly total current assets?
- What is the all time high quarterly current assets for Xilio Therapeutics?
- What is Xilio Therapeutics quarterly current assets year-on-year change?
What is Xilio Therapeutics annual total current assets?
The current annual current assets of XLO is $57.67 M
What is the all time high annual current assets for Xilio Therapeutics?
Xilio Therapeutics all-time high annual total current assets is $57.67 M
What is Xilio Therapeutics annual current assets year-on-year change?
Over the past year, XLO annual total current assets has changed by +$42.52 M (+280.66%)
What is Xilio Therapeutics quarterly total current assets?
The current quarterly current assets of XLO is $63.31 M
What is the all time high quarterly current assets for Xilio Therapeutics?
Xilio Therapeutics all-time high quarterly total current assets is $202.52 M
What is Xilio Therapeutics quarterly current assets year-on-year change?
Over the past year, XLO quarterly total current assets has changed by +$15.18 M (+31.55%)